This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.
Format:
Guideline
Publication Date:
2002
ID:
32401
- Policy Makers
- TB
- Program Management
- TB Treatment
- Treatment Guidelines Materials
- Treatment- Adverse Reactions
- Treatment- Directly Observed Therapy (DOT)
- Treatment- Medication Information